ImmCeRNA (Prediction and Evaluation of Immune-related ceRNA for Personalized Therapy and Prognosis in Pan-cancer), which offers an in-depth identification and exploration of immune-related ceRNAs and their close relationship with immune cell infiltration, immunotherapy, drug sensitivity, and cancer prognosis across 27 human cancer types in a cancer-specific, pan-cancer comparative, and patient individual-specific manner. Through this, it facilitates a better comprehension of the intricate interactions within the tumor microenvironment and contributes to the advancement of personalized medicine and improved patient outcomes.
